Bausch & Lomb (BLCO) Total Current Liabilities (2021 - 2026)
Bausch & Lomb's (BLCO) quarterly Total Current Liabilities came in at $1.9 billion in Q2 2026, up 2.72% YoY from $1.8 billion in Q2 2025, and up 3.85% on a QoQ basis from $1.8 billion in Q1 2026.
Bausch & Lomb (BLCO) Total Current Liabilities (2021 - 2026) Analysis & Trends
Bausch & Lomb (BLCO) has 6 years of Total Current Liabilities data on file, last reported at $1.9 billion in Q2 2026.
- Quarterly Total Current Liabilities rose 2.72% year-over-year to $1.9 billion in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $1.9 billion (up 2.72% YoY) and the FY2025 annual result came in at $1.9 billion, up 10.47% from the prior year.
- Total Current Liabilities improved to $1.9 billion in Q2 2026, from $1.8 billion in the prior quarter.
- In the past five years, Total Current Liabilities ranged from a high of $1.9 billion in Q4 2025 to a low of $1.1 billion in Q1 2022.
- A 5-year average of $1.6 billion and a median of $1.6 billion in 2024 frame the typical range for Total Current Liabilities.
- Annual changes were most pronounced in 2024 — Total Current Liabilities grew 29.94% — and 2026, when it grew 2.72%.
- Tracing BLCO's Total Current Liabilities over 5 years: stood at $1.3 billion in 2022, then advanced by 21.84% to $1.6 billion in 2023, then grew by 10.07% to $1.7 billion in 2024, then grew by 10.47% to $1.9 billion in 2025, then retreated by 1.56% to $1.9 billion in 2026.
- The last three Total Current Liabilities figures came in at $1.9 billion (Q2 2026), $1.8 billion (Q1 2026), and $1.9 billion (Q4 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 135.10 Bn | 129.88 Bn | 1.96 Bn | 1.92 Bn |
| 2 | Becton Dickinson | 52.53 Bn | 51.67 Bn | 2.32 Bn | 9.40 Bn |
| 3 | Alcon | 35.80 Bn | 34.45 Bn | 1.68 Bn | 3.17 Bn |
| 4 | Resmed | 33.98 Bn | 32.51 Bn | 861.22 Mn | 1.40 Bn |
| 5 | Medline | 29.15 Bn | 26.47 Bn | 2.22 Bn | 2.71 Bn |
| 6 | West Pharmaceutical Services | 24.98 Bn | 24.54 Bn | 329.20 Mn | 640.50 Mn |
| 7 | Solventum | 15.36 Bn | 14.96 Bn | 1.29 Bn | 3.66 Bn |
| 8 | Cooper Companies | 14.87 Bn | 14.73 Bn | 735.40 Mn | 1.80 Bn |
| 9 | Baxter International | 13.62 Bn | 11.47 Bn | 1.03 Bn | 3.59 Bn |
| 10 | Bausch & Lomb | 6.18 Bn | 5.81 Bn | 867.00 Mn | 1.89 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.89 Bn |
| Mar 31, 2026 | 1.82 Bn |
| Dec 31, 2025 | 1.92 Bn |
| Sep 30, 2025 | 1.90 Bn |
| Jun 30, 2025 | 1.84 Bn |
| Mar 31, 2025 | 1.73 Bn |
| Dec 31, 2024 | 1.74 Bn |
| Sep 30, 2024 | 1.80 Bn |
| Jun 30, 2024 | 1.68 Bn |
| Mar 31, 2024 | 1.62 Bn |
| Dec 31, 2023 | 1.58 Bn |
| Sep 30, 2023 | 1.39 Bn |
| Jun 30, 2023 | 1.33 Bn |
| Mar 31, 2023 | 1.25 Bn |
| Dec 31, 2022 | 1.30 Bn |
| Sep 30, 2022 | 1.20 Bn |
| Jun 30, 2022 | 1.27 Bn |
| Mar 31, 2022 | 1.09 Bn |
| Dec 31, 2021 | 1.10 Bn |